FindOwnerSearch
Brands and Their Owners
Welcome to the Brand page for “ERBITUX CETUXIMAB”, which is offered here for The mark comprises the words erbitux cetuximab and an antibody design (shown in stippling).;pharmaceutical preparation, monoclonal antibody for the treatment of cancer;color is not claimed as a feature of the mark.;cetuximab;the stippling is for shading purposes.;.
Its status is currently believed to be active. Its class is unavailable. “ERBITUX CETUXIMAB” is believed to be currently owned by “IMCLONE SYSTEMS INCORPORATED”.
Owner: |
IMCLONE SYSTEMS INCORPORATED
Owner Details |
---|---|
Description: |
The mark comprises the words ERBITUX CETUXIMAB and an antibody design (shown in stippling).;PHARMACEUTICAL PREPARATION, MONOCLONAL ANTIBODY FOR THE TREATMENT OF CANCER;Color is not claimed as a feature of the mark.;CETUXIMAB;The stippling is for shading purposes.;
|
Categories: | MARK COMPRISES |